Stromová štruktúra MeSH - protilátky monoklonálne humanizované

[d12.776.124.486.485.114.224.060]

• aminokyseliny, peptidy a proteíny [d12] +
  • proteíny [d12.776] +
    • proteíny krvné [d12.776.124] +
      • imunoproteíny [d12.776.124.486] +
        • imunoglobulíny [d12.776.124.486.485] +
          • protilátky [d12.776.124.486.485.114] +
            • protilátky monoklonálne [d12.776.124.486.485.114.224] +
              • protilátky monoklonálne humanizované [d12.776.124.486.485.114.224.060]
                • abciximab [d12.776.124.486.485.114.224.060.125]
                • adalimumab [d12.776.124.486.485.114.224.060.250]
                • alemtuzumab [d12.776.124.486.485.114.224.060.313]
                • baziliximab [d12.776.124.486.485.114.224.060.344]
                • bevacizumab [d12.776.124.486.485.114.224.060.375]
                • brentuximab vedotin [d12.776.124.486.485.114.224.060.438]
                • certolizumab pegol [d12.776.124.486.485.114.224.060.500]
                • cetuximab [d12.776.124.486.485.114.224.060.750]
                • daklizumab [d12.776.124.486.485.114.224.060.766]
                • denosumab [d12.776.124.486.485.114.224.060.782]
                • gemtuzumab [d12.776.124.486.485.114.224.060.790]
                • inotuzumab ozogamicín [d12.776.124.486.485.114.224.060.794]
                • ipilimumab [d12.776.124.486.485.114.224.060.798]
                • natalizumab [d12.776.124.486.485.114.224.060.813]
                • nivolumab [d12.776.124.486.485.114.224.060.829]
                • omalizumab [d12.776.124.486.485.114.224.060.844]
                • palivizumab [d12.776.124.486.485.114.224.060.860]
                • panitumumab [d12.776.124.486.485.114.224.060.864]
                • ramucirumab [d12.776.124.486.485.114.224.060.866]
                • ranibizumab [d12.776.124.486.485.114.224.060.868]
                • trastuzumab [d12.776.124.486.485.114.224.060.875] +
                • ustekinumab [d12.776.124.486.485.114.224.060.937]
              • protilátky monoklonálne myšie [d12.776.124.486.485.114.224.075] +
              • terapeutiká protilátkové kombinované [d12.776.124.486.485.114.224.342]
              • infliximab [d12.776.124.486.485.114.224.608]
              • protilátky jednoreťazcové [d12.776.124.486.485.114.224.785]

[d12.776.124.790.651.114.224.060]

• aminokyseliny, peptidy a proteíny [d12] +
  • proteíny [d12.776] +
    • proteíny krvné [d12.776.124] +
      • globulíny sérové [d12.776.124.790] +
        • imunoglobulíny [d12.776.124.790.651] +
          • protilátky [d12.776.124.790.651.114] +
            • protilátky monoklonálne [d12.776.124.790.651.114.224] +
              • protilátky monoklonálne humanizované [d12.776.124.790.651.114.224.060]
                • abciximab [d12.776.124.790.651.114.224.060.125]
                • adalimumab [d12.776.124.790.651.114.224.060.250]
                • alemtuzumab [d12.776.124.790.651.114.224.060.375]
                • baziliximab [d12.776.124.790.651.114.224.060.407]
                • bevacizumab [d12.776.124.790.651.114.224.060.438]
                • brentuximab vedotin [d12.776.124.790.651.114.224.060.469]
                • certolizumab pegol [d12.776.124.790.651.114.224.060.500]
                • cetuximab [d12.776.124.790.651.114.224.060.750]
                • daklizumab [d12.776.124.790.651.114.224.060.766]
                • denosumab [d12.776.124.790.651.114.224.060.782]
                • gemtuzumab [d12.776.124.790.651.114.224.060.790]
                • inotuzumab ozogamicín [d12.776.124.790.651.114.224.060.794]
                • ipilimumab [d12.776.124.790.651.114.224.060.798]
                • natalizumab [d12.776.124.790.651.114.224.060.813]
                • nivolumab [d12.776.124.790.651.114.224.060.829]
                • omalizumab [d12.776.124.790.651.114.224.060.844]
                • palivizumab [d12.776.124.790.651.114.224.060.860]
                • panitumumab [d12.776.124.790.651.114.224.060.864]
                • ramucirumab [d12.776.124.790.651.114.224.060.866]
                • ranibizumab [d12.776.124.790.651.114.224.060.868]
                • trastuzumab [d12.776.124.790.651.114.224.060.875] +
                • ustekinumab [d12.776.124.790.651.114.224.060.937]
              • protilátky monoklonálne myšie [d12.776.124.790.651.114.224.075] +
              • terapeutiká protilátkové kombinované [d12.776.124.790.651.114.224.306]
              • infliximab [d12.776.124.790.651.114.224.537]

[d12.776.377.715.548.114.224.200]

• aminokyseliny, peptidy a proteíny [d12] +
  • proteíny [d12.776] +
    • globulíny [d12.776.377] +
      • globulíny sérové [d12.776.377.715] +
        • imunoglobulíny [d12.776.377.715.548] +
          • protilátky [d12.776.377.715.548.114] +
            • protilátky monoklonálne [d12.776.377.715.548.114.224] +
              • protilátky monoklonálne humanizované [d12.776.377.715.548.114.224.200]
                • abciximab [d12.776.377.715.548.114.224.200.125]
                • adalimumab [d12.776.377.715.548.114.224.200.250]
                • alemtuzumab [d12.776.377.715.548.114.224.200.375]
                • baziliximab [d12.776.377.715.548.114.224.200.407]
                • bevacizumab [d12.776.377.715.548.114.224.200.438]
                • brentuximab vedotin [d12.776.377.715.548.114.224.200.469]
                • certolizumab pegol [d12.776.377.715.548.114.224.200.500]
                • cetuximab [d12.776.377.715.548.114.224.200.750]
                • daklizumab [d12.776.377.715.548.114.224.200.766]
                • denosumab [d12.776.377.715.548.114.224.200.782]
                • gemtuzumab [d12.776.377.715.548.114.224.200.790]
                • inotuzumab ozogamicín [d12.776.377.715.548.114.224.200.794]
                • ipilimumab [d12.776.377.715.548.114.224.200.798]
                • natalizumab [d12.776.377.715.548.114.224.200.813]
                • nivolumab [d12.776.377.715.548.114.224.200.829]
                • omalizumab [d12.776.377.715.548.114.224.200.844]
                • palivizumab [d12.776.377.715.548.114.224.200.860]
                • panitumumab [d12.776.377.715.548.114.224.200.864]
                • ramucirumab [d12.776.377.715.548.114.224.200.866]
                • ranibizumab [d12.776.377.715.548.114.224.200.868]
                • trastuzumab [d12.776.377.715.548.114.224.200.875] +
                • ustekinumab [d12.776.377.715.548.114.224.200.937]
              • protilátky monoklonálne myšie [d12.776.377.715.548.114.224.284] +
              • terapeutiká protilátkové kombinované [d12.776.377.715.548.114.224.463]
              • infliximab [d12.776.377.715.548.114.224.642]